Mexico’s Covid-19 vaccine distribution contract with the Chinese pharmaceutical company CanSino Biologics It ended in November, Foreign Minister Marcelo Ebrard said Tuesday.
Reuters reported last week that the Latin American country reduced its order to CanSino Biologics in July to around 14.5 million doses from the initially scheduled 35 million, as supply from other sources increased, although the company said it planned to continue with the deliveries in 2022.
“CanSino was concluded in November,” Ebrard told the president’s daily conference. Andrés Manuel López Obrador.
The foreign minister placed the Chinese firm among a group of companies with which Mexico has concluded contracts and said that the government has received the doses of vaccines agreed with them.